Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain–Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review

Introduction Small cross-sectional studies and case reports observed improvement after administration of second IVIG dose (SID) amongst Guillain–Barré Syndrome (GBS) patients not responsive to initial IVIG cycle. Nevertheless, recent clinical trial and larger observational studies did not find any p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta neurologica Belgica 2024-08, Vol.124 (4), p.1237-1250
Hauptverfasser:	Prado, Mario B., Adiao, Karen Joy B., Turalde, Christian Wilson R., Dasig, Darwin A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Guillain-Barre Syndrome - drug therapy Humans Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - administration & dosage Immunologic Factors - therapeutic use Medicine/Public Health Neurology Neuroradiology Neurosciences Retreatment Review Article Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!